PHARMACEUTICAL COMPOSITION COMPRISING N-3-CHLORO-4-(3-FLUOROPHENYL)METHOXYPHENYL-6-52-(METHYLSULFONYL)ETHYLAMINOMETHYL-2-FURYL-4-QUINAZOLINAMINE

摘要

The present invention relates to a pharmaceutical composition comprising N-[3-chloro-4- [(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4- quinazolinamine as activepharmaceuti-cal ingredient and a process of preparing such composition.